Banka Bioloo Ltd (BANKA) is currently trading at 61.46 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Banka Bio is an integrated sanitation and water-regeneration company delivering design, engineering, execution and lifecycle operations of sewage, fecal sludge and wastewater treatment solutions, operating both as an engineering/ops arm and through its Megaliter Varunaa platform that funds and owns treatment assets to deliver long-term customer contracts. FY26 showed recovery with consolidated total income of ₹58.39 crore (+7.1% YoY), EBITDA recovery to ₹6.49 crore (₹5.20 crore excluding other income) and a marginal Group PAT of ₹0.39 crore, while management highlights FY27 priority to convert contracted revenues into cash and sustainable pre‑tax profitability. Megaliter Varunaa is a distinct capital-and-contract platform with a contracted portfolio LTV of ~₹122 crore, 16 contracted projects and a stated project-level post-tax IRR target above 20%; Megaliter recognised ₹5.86 crore turnover in FY26, underscoring early-stage revenue recognition versus multi-year LTV. The company carries a sizeable short-term working-capital burden — trade receivables ₹29.15 crore and contract assets ₹9.42 crore as of 31 March 2026 — and reports adjusted net debt of ₹28.88 crore with improved liquidity following external equity into Megaliter, making collections and working-capital discipline material execution risks. Strategic traction includes geographic expansion into Bengaluru and Mumbai, large developer clients (Brigade, Reliance, RMZ) and DRDO technology licensing, positioning Banka Bio to monetise recurring O&M and subscription-style contracts across residential, commercial and railway segments.

Over the past 52 weeks, Banka Bioloo Ltd has traded between a low of ₹41.00 and a high of ₹96.58. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Banka Bioloo Ltd has a market capitalization of approximately 67.19. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Banka Bioloo Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 191.97 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 67.19 Cr, Banka Bioloo Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Banka Bioloo Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Banka Bioloo Ltd is 191.97. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.